Rodin Therapeutics
Rodin Therapeutics was a biotechnology company that developed treatments for Alzheimer's disease. Founded in 2013, it was acquired in 2019 by Alkermes.
3
Funding Rounds
$39.9m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| An*** Ma******* |
|
- | linkedin twitter |
| Br*** Bo*** |
|
- | linkedin twitter facebook |
Industries
Rodin Therapeutics is active in the following industries: